fluorobenzenes has been researched along with Takotsubo Cardiomyopathy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujiwara, W; Hayashi, M; Ito, T; Izawa, H; Kamada, T; Mukaide, D; Ozaki, Y; Sugishita, Y; Yokoi, H; Yoshikawa, D; Yoshinaga, M | 1 |
E Madias, J | 1 |
2 other study(ies) available for fluorobenzenes and Takotsubo Cardiomyopathy
Article | Year |
---|---|
Takotsubo cardiomyopathy with involvement of delayed-onset rhabdomyolysis and acute kidney injury after rosuvastatin treatment.
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Aged; Diagnosis, Differential; Electrocardiography; Fluorobenzenes; Heart Ventricles; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrimidines; Rhabdomyolysis; Rosuvastatin Calcium; Sulfonamides; Takotsubo Cardiomyopathy; Treatment Outcome; Withholding Treatment | 2015 |
Persistent Excessive Electrocardiogram ST-segment Elevation in a Patient with a Takotsubo Syndrome: What Could be the Cause?
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrimidines; Rhabdomyolysis; Sulfonamides; Takotsubo Cardiomyopathy | 2016 |